Showing results (541-550 of 3,697) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|August 19, 2007
Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experienceAkira Ozawa, Nozomu Tanji, Tatsumasa Ochi, et al.International Journal of Clinical Oncology|August 19, 2007
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancersMari Jiko, Ikuko Yano, Eriko Sato, et al.International Journal of Clinical Oncology|August 19, 2007
A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1Rieko Nakamura, Yoshiro Saikawa, Koushi Kumagai, et al.International Journal of Clinical Oncology|August 19, 2007
Endometrial carcinosarcoma presenting as a tibial metastasisMasako Ishibashi, Ritsuto Fujiwaki, Ichiro Nakayama, et al.International Journal of Clinical Oncology|December 19, 2008
Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexateYasushi Goto, Noriyuki Katsumata, Shunichi Nakai, et al.International Journal of Clinical Oncology|December 19, 2008
Long-term complete response of multiple hepatic metastases from carcinoma of the papilla of Vater using intrahepatic infusion of 5-FU with low-dose cisplatin following pancreaticoduodenectomyShuhei Komatsu, Teruhisa Sonoyama, Toshiya Ochiai, et al.International Journal of Clinical Oncology|August 16, 2008
Glycosylation in bladder cancerChikara OhyamaInternational Journal of Clinical Oncology|August 16, 2008
PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flowShinichi Kinami, Takashi Fujimura, Eisuke Ojima, et al.International Journal of Clinical Oncology|August 16, 2008
Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancerFaruk Tas, Duygu Derin, Nese Guney, et al.International Journal of Clinical Oncology|August 16, 2008
Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancerYoh Watanabe, Eiji Koike, Hidekatsu Nakai, et al.Pageof 370